Red cell adenosine deaminase (ADA-RBC) activity in patients with myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria is significantly increased compared to that observed in normal controls. ADA-RBC activity is not related to fetal hemoglobin concentration, but it is significantly correlated with hemoglobin concentration at diagnosis and with the degree of morphologic dysplasia in the erythroid lineage. The results of our study suggest that the observed enzymatic abnormality may constitute a non-specific manifestation of the stem cell alteration that determines these disorders.
Get full access to this article
View all access options for this article.
References
1.
BennettJ.M., CatovskyD., DanielM.T., FlandrinG., GaltonD.A.G., GralnickH.R., SultanC.: Proposal for the classification of the myelodysplastic syndromes.Br. J. Haematol., 51: 189–199, 1982.
2.
BetkeK., MartiH.R., SchlichtI.: Estimation of small percentages of foetal haemoglobin.Nature, 184: 1877–1878, 1959.
3.
BeutlerE.: Adenosine deaminase. In: Red cell metabolism: a manual of biochemical methods.BeutlerE. (Ed.) (2nd edn), pp. 99–100, Grune & Stratton, New York, 1975.
4.
GabbianelliM., PelosiE., LabbayeC., ValtieriM., TestaU., PeschleC.: Reactivation of HbF synthesis in normal adult erythroid bursts by IL-3.Br. J. Haematol., 74: 114–117, 1990.
5.
GebbiaV., MiserendinoV., MiceliS., ColucciA., Tambone ReyesM., RausaL., Di MarcoP., CitarrellaP.: Analysis of human dysplastic haematopoiesis in long term bone marrow culture.Blut, 59: 442–448, 1989.
6.
GladerB.E., BackerK.: Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases.Br. J. Haematol., 68: 165–168, 1988.
7.
GladerB.E., BackerK., DiamondL.K.: Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia.N. Engl. J. Med., 309: 1486–1490, 1983.
8.
GreenbergP.L.: In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.Clin. Haematol., 15: 973–993, 1986.
9.
HopkinsonD.A., CookP.H., HarrisH.: Further data on the adenosine deaminase polymorphism and a report of a new phenotype.Ann. Hum. Genet., 32: 361–367, 1969.
10.
JunejaS.K., ImbertM., JoualtH., ScoazecJ.Y., SigauxF., SultanC.: Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.J. Clin. Pathol., 36: 1129–1135, 1983.
11.
LintulaR.: Red cell enzymes in myelodysplastic syndromes: a review.Scand. J. Haematol., 36 Suppl., 45: 56–59, 1986.
12.
UmemuraT., Al-KhattiA., PapayannopoulouT., StamatoyannopoulosG.: Fetal hemoglobin synthesis in vivo: direct evidence for control at the level of erythroid progenitors.Proc. Natl. Acad. Sci. USA, 85: 9278–9282, 1988.
13.
Van Der WeydenM.B., HarrisonC., HallamL., McVeighD., Eng GanT., TaaffeL.M.: Elevated red cell adenosine deaminase and haemolysis in a patient with myelodysplastic syndrome.Br. J. Haematol., 73: 129–131, 1989.
14.
Van KampenE.J., ZijlstraW.G.: Standardization of hemoglobinometry. II. The hemoglobincyanide method.Clin. Chim. Acta, 6: 538–545, 1961.
